TLR signaling inhibitor, phenylmethimazole, in combination with tamoxifen inhibits human breast cancer cell viability and migration

Heightened co-expression and dysregulated signaling associated with Toll-like receptor 3 (TLR3) and Wnt5a is an integral component of solid tumors and hematological malignancies. Our previous findings in pancreatic cancer and melanoma suggest that inhibition of these pathways by a TLR3 signaling inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Anthony L., Dickerson, Eric, Dagia, Nilesh, Malgor, Ramiro, McCall, Kelly D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768328/
https://www.ncbi.nlm.nih.gov/pubmed/29371911
http://dx.doi.org/10.18632/oncotarget.10358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768328/
https://www.ncbi.nlm.nih.gov/pubmed/29371911
http://dx.doi.org/10.18632/oncotarget.10358

Ejemplares similares